Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction

National guidelines recommend sentinel lymph node biopsy (SLNB) be offered to patients with > 10% likelihood of sentinel lymph node (SLN) positivity. On the other hand, guidelines do not recommend SLNB for patients with T1a tumors without high-risk features who have < 5% likelihood of a positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitman, Eric D., Koshenkov, Vadim P., Gastman, Brian R., Lewis, Deri, Hsueh, Eddy C., Pak, Ho, Trezona, Thomas P., Davidson, Robert S., McPhee, Michael, Guenther, J. Michael, Toomey, Paul, Smith, Franz O., Beitsch, Peter D., Lewis, James M., Ward, Andrew, Young, Shawn E., Shah, Parth K., Quick, Ann P., Martin, Brian J., Zolochevska, Olga, Covington, Kyle R., Monzon, Federico A., Goldberg, Matthew S., Cook, Robert W., Fleming, Martin D., Hyams, David M., Vetto, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457832/
https://www.ncbi.nlm.nih.gov/pubmed/34568719
http://dx.doi.org/10.1200/PO.21.00162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457832/
https://www.ncbi.nlm.nih.gov/pubmed/34568719
http://dx.doi.org/10.1200/PO.21.00162

Ejemplares similares